Europe’s First Adult-Use Cannabis Dispensaries: Switzerland Greenlights Experimental Sales Project – Benzinga

Loading…Loading…Loading…

In a groundbreaking move, the Swiss Federal Office of Public Health (BAG) has granted approval to the Swiss Institute for Addiction and Health Research (ISGF) and the Sanity Group to initiate a pilot study on the controlled dispensing of recreational cannabis in the canton of Basel-Landschaft. This study, named the “Grashaus Projects,” is set to commence later this year, with the primary objective of understanding the implications of regulated cannabis access. Insights derived will inform potential future cannabis regulations in Switzerland.

Sanity Group, a German entity, is the sole non-Swiss company involved in the Swiss pilot projects. It will start the dispensing process through a store in Allschwil, followed by another one in Liestal.

See also: The ‘Father Of Cannabis Research’ Discovered Something More Potent Than THC Before Dying: Here’s What

The ISGF-Sanity collaboration received the final nod from the BAG after previously securing the blessings of the Ethics Committee Northwest and Central Switzerland (EKNZ) last year. Prof. Dr. Michael Schaub, the scientific director of the ISGF, will lead the study, which will focus on the regulated sale of cannabis for non-medical use.

The research intends to document consumption patterns and the subsequent physical and mental health impacts on the participants. Additionally, the societal consequences,

Read More Here...